A new state-of-the-art Imaging System, entirely donated by the Onassis Foundation, joins the fight against skin cancer at “Andreas Syggros” Hospital

The donation of VECTRA WB360 followed the overall reconstruction of the Melanoma and Skin Cancer Center, which was completed in 2018 with the support of the Onassis Foundation. A modern and functional space was built inside the “Andreas Syggros” Hospital, receiving more than 40 skin cancer patients on a daily basis and making a major contribution to the fight against a rapidly growing disease that has been turning into a modern plague, with approximately 1,000 new melanoma and skin cancer diagnoses annually at the “Andreas Syggros” Hospital alone, which means that this is a public health emergency. The new Center extends over an area of 240 sq.m. (three times the size of the previous one) and includes four consultation rooms, a room for minimally invasive procedures, a staff area, as well as a room which hosts the library, conferences and patient interviews. As of today, VECTRA WB360, a synonym for medical innovation and research in the field of dermatology, will safeguard this extraordinary work undertaken in this Center.

• This system, which can offer 3D imaging through 92 cameras that take snapshots, is the future of Dermatology and Skin Oncology, since it allows to monitor all the patient’s lesions at the same time, as well as their evolution over time.
• One 3D capture covers nearly all of the patient's skin, saving photography time and improving patient comfort.
• Ultra-high resolution 3D images reduce the number of close-up images required.
• The Artificial Intelligence algorithms integrated into VECTRA WB360 allow for automated capture of all lesions on the patient's skin, offering at the same time the possibility to compare them in sequential images.
• In practice, the 3D overview image, close-up photographs, searchable attributes, and medical notes provide the clinical history for each tagged lesion.
• In its early applications, the system will be used in patients with melanoma history or increased risk to develop skin cancer (history of skin cancer, family history of melanoma, extended exposure to sunlight with multiple burns, etc.). At a later stage, it may also be used in healthy people for skin cancer prevention, as well as other dermatological patients, for follow-up purposes on a wide range of skin diseases, such as psoriasis, vitiligo, bullous dermatoses, burn management, etc.